Activity

The increasing activity in the medical oncology department during the past years, has allowed us to develop an integrative and personalized treatment to patients, focused in the different care perspectives that affect quantity and quality of life. Personalized care always guided by the different expert physicians of the multidisciplinary oncological team. 

Outpatient activity has grown exponentially from 1993 to 2015, from 700 first visits to 1.700, and from 7.000 to 23.000 second visits. In our hospital day we administer 100-120 daily treatments, in 28 armchairs. 

The clinical trials unit offers 1oo different trials by year for the different types of cancer, with a median of 300 patients included annually. Has 6 armchairs for the administration of the novel therapies. 

Inpatient care unit has 30 beds, 6 dedicated to palliative care. Hospitalized patients are attended by 3 teams of specialized physicians in multimodality/integral attention. 

Lines of care

  • MELANOMA

  • BREAST CANCER

  • DIGESTIVE CANCER

  • UROLOGENITAL CANCER

  • BRAIN CANCER

  • HEAD AND NECK CANCER

  • GYNECOLOGICAL CANCER

  • LUNG CANCER

Diagnosis in Oncology

Material resources

  • MOLECULAR DIAGNOSIS


    Expertise in pathological studies

  • CLINICAL TRIALS UNIT


    Research studies with novel therapies in the different levels of development: clinical trials from phase I to phase IV.

  • HOSPITAL DAY TREATMENTS


    Chemotherapy, targeted therapy and immunotherapy

  • RADIOTHERAPY TREATMENTS


    Including IMRT (intensity modulated radiotherapy), intraoperative radiotherapy and brachiterapy.

  • LOCAL THERAPIES


    Liver chemo/radioembolization, radiofrequency and microwaves for lung and liver metastases

  • HIGH COMPLEXITY SURGERIES


    Including cytoreductive surgeries with HIPEC microwaves (Hyperthermic Intraperitoneal Chemotherapy) for lung and liver metastases

  • PSYCHOLOGISTS AND PSYCHIATRISTS


    Specialized in oncological patients

  • SUPPORTIVE/PALLIATIVE CARE


    ESMO accreditated center

  • INTENSIVE CARE UNIT

The medical team is 100% dedicated to oncological patients. As a result, our patients are always seen by the same team of physicians throughout the entire procedure. 

Specially trained hospital nurses and nursing assitants, have extensive experience in the care of these patients with a nurse-to-patient ratio that is never more than 1:6. 

Запланировать встречу

Our results

Stem Cells Transplant

36.500

treatments in hospital day
percutaneous coronary

1.700

FIRST VISITS

 percutaneous coronary

23.000

SECOND VISITS
percutaneous coronary

300

Patient included in clinical trials

 percutaneous coronary

100

Diferent clinical trials

Oncology blog

  • An early diagnosis of colorectal cancer improves prognosis

    Colorectal cancer has a high impact in western countries. In Spain it’s the most frequent tumour among men and women, above lung cancer and breast cancer. Every year in our country more than 40,000 cases are diagnosed and the tendency is going up, in large part due to the influence of risk factors as the population […] La entrada An early diagnosis of colorectal cancer improves prognosis aparece primero en Blog sobre diagnóstico y tratamiento del CÁNCER.

    Read more

  • Liquid biopsy, diagnosis of non-invasive cancer, personalised treatment and follow-up

    Liquid biopsy or fluid biopsy is a new cancer diagnosis and follow-up test. It consists of a blood test that can either confirm or rule out the presence of tumour cells in the blood and, if present, analyse their DNA to personalise or adapt the treatment. NON-INVASIVE CANCER DIAGNOSIS Until recently, to diagnose cancer or to monitor its progression, it was necessary to […] La entrada Liquid biopsy, diagnosis of non-invasive cancer, personalised treatment and follow-up aparece primero en Blog sobre diagnóstico y tratamiento del CÁNCER.

    Read more

  • New barnaclínic+ genetic test to detect risk of cancer, early diagnosis and prevention

    For the past few days, barnaclínic+ has been offering the possibility of carrying out a genetic test to detect cancer risk. It is an early detection test for the risk of developing some types of cancer and, above all, what is known as hereditary cancer. WOULD YOU LIKE MORE INFORMATION ABOUT THE BARNACLÍNIC+ GENETIC STUDY OF CANCER RISK? FURTHER INFORMATION La entrada New barnaclínic+ genetic test to detect risk of cancer, early diagnosis and prevention aparece primero en Blog sobre diagnóstico y tratamiento del CÁNCER.

    Read more